Table 2.

Geometric means^a (95% CIs) of urinary isoflavonoids and creatinine among cases and control subjects

	Cases	Control subjects	Ratiosb	Pc
Women
Total isoflavonoids	19.4 (16.1, 23.3)	18.2 (16.0, 20.8)	1.07	0.59
Daidzein	7.09 (5.89, 8.54)	6.76 (5.93, 7.72)	1.05	0.68
Genistein	3.35 (2.72, 4.13)	3.12 (2.69, 3.61)	1.08	0.58
Glycitein	1.12 (0.91, 1.37)	1.15 (0.99, 1.32)	0.98	0.85
Equol	0.11 (0.07, 0.16)	0.14 (0.11, 0.19)	0.77	0.31
O-DMAd	0.68 (0.50, 0.93)	0.73 (0.58, 0.90)	0.94	0.76
Dihydrodaidzein	0.66 (0.48, 0.90)	0.82 (0.65, 1.02)	0.81	0.28
Dihydrogenistein	0.20 (0.15, 0.28)	0.25 (0.20, 0.31)	0.81	0.28
Creatinine	74.1 (67.1, 81.8)	66.2 (61.7, 71.0)	1.12	0.07
Men
Total isoflavonoids	13.5 (11.0, 16.6)	14.8 (12.8, 17.2)	0.91	0.46
Daidzein	5.24 (4.26, 6.44)	5.60 (4.84, 6.48)	0.94	0.61
Genistein	2.42 (1.93, 3.04)	2.61 (2.23, 3.07)	0.93	0.59
Glycitein	0.78 (0.62, 0.98)	0.83 (0.70, 0.97)	0.94	0.68
Equol	0.05 (0.03, 0.07)	0.07 (0.05, 0.09)	0.70	0.16
O-DMA	0.41 (0.29, 0.57)	0.46 (0.36, 0.58)	0.88	0.57
Dihydrodaidzein	0.74 (0.54, 1.03)	0.66 (0.53, 0.83)	1.13	0.55
Dihydrogenistein	0.19 (0.14, 0.26)	0.21 (0.17, 0.25)	0.95	0.79
Creatinine	70.9 (64.4, 78.1)	74.2 (69.3, 79.4)	0.96	0.45

^aExpressed as nmol/mg creatinine for isoflavonoids, and mg/dl for creatinine.

^bRatios of geometric means for cases vs control subjects.

^cP values for case–control differences in means of log transformed isoflavonoids.

^dO-DMA: O-desmethylangolensin.